System and method for quantitatively assessing diabetic cardiac autonomic neuropathy in type I diabetic biological subject
US8909328B2 · kind B2 · utility
43Cited by
1References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 25, 2013 |
| Grant date | Dec 9, 2014 |
| Priority date | — |
| Expiry date | Jul 25, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/742
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present disclosure provides a method and an apparatus for identifying development of diabetic cardiovascular autonomic neuropathy (DCAN) in a biological subject. In one aspect, the method includes collecting data associated with heart rates of a biological subject, and processing the collected data to extract primary and secondary components of the collected data by performing a principal dynamic mode (PDM) analysis. A significant reduction of the primary or secondary component at a predetermined time period can be indicative of the DCAN development.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.